Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Management Board

Chairman and Scientific Director

Prof. Dr. med. Dr. h. c. Michael Baumann

Prof. Dr. med. Dr. h. c. Michael Baumann
© DKFZ / Uwe Anspach

After completing his medical studies at the University of Hamburg, Professor Michael Baumann obtained his Doctorate in Medicine in 1988. He then worked as a postdoctoral fellow at Massachusetts General Hospital at the Harvard Medical School in Boston. After his training as a specialist for radiotherapy he habilitated in 1994 in Hamburg. In 1995, he changed to the Faculty of Medicine Carl Gustav Carus in Dresden as Head of Experimental Radiooncology. In 2001 the Dresden University of Technology appointed Michael Baumann as Professor for Radiooncology. During his time as Chair of the Department of Radiation Oncology at the University Hospital Carl Gustav Carus, director at the Institute for Radiooncology at the Helmholtz Center Dresden-Rossendorf, as well as director of the OncoRay Center, he significantly contributed to the radiooncological research in Dresden. Furthermore, he was the founding director of the University Cancer Center Dresden and spokesperson of the DKTK and NCT partner site Dresden. His research focuses on translational-orientated experimental radiotherapy and radiobiology, as well as the treatment of lung and head and neck cancer.

Michael Baumann has been honored with numerous scientific awards including the Michael Fry Research Award of the Radiation Research Society, the Breur Gold Medal and Regaud Medal Award of the European Society for Therapeutic Radiology and Oncology. In 2004, he was appointed as a member of the National Academy of Science (Leopoldina) and has been President of the European Society for Radiotherapy and Oncology (ESTRO), the European CanCer Organisation (ECCO) and the German Society for Radiation Oncology (DEGRO). In 2022, the University of Aarhus, Denmark, awarded him an honorary doctorate.

He has been Chairman and Scientific Director of DKFZ since November 1st 2016.

Assistants to the Scientific Director: 

Dr. Sabine Gajewski
Tel. +49(0)6221 42-1694
Contact Form

Dr. Nina Pfisterer
Tel. +49(0)6221 42-1704
Contact Form

 

Secretariat:

Caroline Benke
Tel. +49(0)6221 42-2851
Contact Form

Nicole Tänzler
Phone: +49(0)6221 42-2841
Contact Form

Administrative Director

Ursula Weyrich

Ursula Weyrich
© Jutta Jung/DKFZ

Ursula Weyrich studied law in Mainz and Clermont-Ferrand, completing her legal training in 1998 with the bar examination. She initially worked as a lawyer, specializing in labor, corporate, and tax law, before moving to the German Federal Ministry for Education and Research (BMBF) as policy officer, where she was responsible, among other things, for the merger of the GMD Research Center Information Technology with the Fraunhofer-Gesellschaft. After a period spent working as the personal assistant to the permanent secretary at BMBF, she became head of division at BMBF in 2006. In that capacity, she was responsible for the Helmholtz centers in Jülich and Karlsruhe, the Max Planck Institute for Plasma Physics (IPP), and for setting up the W7-X fusion experiment in Greifswald. Her responsibilities also included assisting with the merger of the University of Karlsruhe and the Research Center Karlsruhe to form the Karlsruhe Institute of Technology (KIT).

At the end of 2008, as an administrative founding board member, Ursula Weyrich assumed responsibility for setting up the German Center for Neurodegenerative Diseases. She was Administrative Managing Director of the GSI Helmholtz Centre for Heavy Ion Research and the Facility for Antiproton and Ion Research in Europe (FAIR) GmbH in Darmstadt since November 2014 and has been Administrative Director of DKFZ since January 1st 2020.



Assistants to the Administrative Director:

Dr. Leonie Backeberg
Phone: +49(0)6221 42-2668
Contact Form

Lena Ebert
Phone: +49(0)6221 42-2605
Contact Form

Christopher Markert
Phone: +49(0)6221 42-2460
Contact Form

Secretariat:

Tina Berdel
Phone: +49(0)6221 42-2861
Contact Form

to top
powered by webEdition CMS